ArticleEuropean heart journal. Case reports2025
Cardiac transplant-associated complete AV block treated with a leadless pacemaker: a case report.
Article in European heart journal. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Complete atrioventricular (AV) block is a rare complication immediately following orthotopic heart transplantation (OHT), typically attributed to ischaemic injury or surgical trauma. In immunosuppressed patients, pacemaker selection requires careful consideration due to heightened infection risk. Case summary: We present a 48-year-old woman with hypertrophic cardiomyopathy who developed persistent complete AV block with no ventricular escape following OHT. The early postoperative period was complicated by right ventricular failure and severe systemic infections. After stabilization, on Day 32 post-transplant, a Micra AV2 leadless pacemaker was implanted due to high infectious risk and presence of moderate-to-severe tricuspid regurgitation. The procedure was successful, with no complications and adequate AV synchrony after optimization. The patient remained clinically stable, with no pacemaker-related complications or rejection on biopsy, and was discharged on Day 45. Discussion: This is the first reported case of Micra AV2 implantation in a transplant recipient. Leadless AV-synchronous pacemakers may be an ideal option in select patients early post-transplant, especially those at high risk for infection and with tricuspid valve dysfunction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.